Cannabis producer Tilray (NASDAQ:TLRY) jumped over 20 percent in value after announcing new additions to its C-suite.

The company confirmed on Tuesday (January 14) that it has hired former Revlon (NYSE:REV) commercial executive Jon Levin as its chief operating officer, while Michael Kruteck, a former executive with privately held Pharmaca Integrative Pharmacy most recently and Molson Coors Beverage (NYSE:TAP,TSX:TAP) previously, has joined as its new chief financial officer.

Shares of the company closed Tuesday’s session at US$21.22, representing a 22.31 percent hike for the day. During after-hours trading, the firm was up an additional 0.85 percent as of 4:23 p.m. EST.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

“Jon and Michael come to Tilray with extensive expertise in their respective fields and we look forward to their contributions as we pioneer the future of cannabis and hemp around the world,” Brendan Kennedy, CEO of Tilray, said in a press release.

stock chart for TLRY

Last year, Tilray was hit with severe share price and valuation drops as part of a grueling year for the marijuana industry. In 2019, the share price of the company declined by 76.74 percent, resulting in a loss per share of US$53.68. The company finished the year with a share price of US$16.27.

Tilray has faced one of the most volatile paths in the cannabis stock market since its original initial public offering in 2018. The company originally faced a frenetic trading pace, which led it to at one point be priced at US$300 per share.

Last summer, Tilray pursued a deal with its largest investor, Privateer Holdings, in order to lock up the shares owned by Privateer and create special restrictions for them.

“We believe this transaction will give Tilray greater control and operating flexibility, while allowing us to effectively manage our public float,” Mark Castaneda, who was chief financial officer for Tilray at the time, said about the deal.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less